FEDERATED HERMES, INC. - ADVERUM BIOTECHNOLOGIES INC ownership

ADVERUM BIOTECHNOLOGIES INC's ticker is ADVM and the CUSIP is 00773U108. A total of 144 filers reported holding ADVERUM BIOTECHNOLOGIES INC in Q2 2020. The put-call ratio across all filers is 0.32 and the average weighting 0.8%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of ADVERUM BIOTECHNOLOGIES INC
ValueSharesWeighting
Q2 2022$6,000
-53.8%
4,901
-51.7%
0.00%
Q1 2022$13,000
+30.0%
10,147
+83.7%
0.00%
Q4 2021$10,0000.0%5,525
+20.0%
0.00%
Q3 2021$10,000
+400.0%
4,603
+941.4%
0.00%
Q2 2021$2,000
-99.8%
442
-99.5%
0.00%
-100.0%
Q3 2020$861,000
-81.9%
83,617
-63.3%
0.00%
-83.3%
Q2 2020$4,754,000
+79133.3%
227,691
+48344.9%
0.01%
Q2 2019$6,0000.0%470
-59.1%
0.00%
Q2 2018$6,000
-14.3%
1,1500.0%0.00%
Q1 2018$7,000
-12.5%
1,150
-52.2%
0.00%
Q4 2017$8,000
+60.0%
2,407
+86.4%
0.00%
Q3 2017$5,0001,2910.00%
Other shareholders
ADVERUM BIOTECHNOLOGIES INC shareholders Q2 2020
NameSharesValueWeighting ↓
Versant Venture Management, LLC 5,068,233$17,739,0005.88%
Sonic Fund II, L.P. 6,552,068$22,932,0001.69%
SAN FRANCISCO SENTRY INVESTMENT GROUP (CA) 480,000$1,680,0000.88%
Avoro Capital Advisors LLC 6,950,000$24,325,0000.42%
RTW INVESTMENTS, LP 7,357,917$25,753,0000.39%
K2 PRINCIPAL FUND, L.P. 898,307$3,144,0000.26%
Artal Group S.A. 3,000,000$10,500,0000.21%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,827,000$9,895,0000.18%
WS MANAGEMENT LLLP 307,442$1,076,0000.11%
ALGERT GLOBAL LLC 82,145$288,0000.10%
View complete list of ADVERUM BIOTECHNOLOGIES INC shareholders